KR101347910B1 - a Food Composition, a Cosmetic Composition, a Pharmaceutical Composition Comprising Supercritical Fluid Extract of Ginger and Extract of Dropwort Fermented - Google Patents

a Food Composition, a Cosmetic Composition, a Pharmaceutical Composition Comprising Supercritical Fluid Extract of Ginger and Extract of Dropwort Fermented Download PDF

Info

Publication number
KR101347910B1
KR101347910B1 KR1020120010048A KR20120010048A KR101347910B1 KR 101347910 B1 KR101347910 B1 KR 101347910B1 KR 1020120010048 A KR1020120010048 A KR 1020120010048A KR 20120010048 A KR20120010048 A KR 20120010048A KR 101347910 B1 KR101347910 B1 KR 101347910B1
Authority
KR
South Korea
Prior art keywords
extract
ginger
cosmetic composition
fermented
composition
Prior art date
Application number
KR1020120010048A
Other languages
Korean (ko)
Other versions
KR20130088665A (en
Inventor
양선아
이은주
정연섭
최희돈
김민주
임효권
이삼빈
이인선
김형대
Original Assignee
계명대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 계명대학교 산학협력단 filed Critical 계명대학교 산학협력단
Priority to KR1020120010048A priority Critical patent/KR101347910B1/en
Priority to PCT/KR2012/008252 priority patent/WO2013115456A1/en
Publication of KR20130088665A publication Critical patent/KR20130088665A/en
Application granted granted Critical
Publication of KR101347910B1 publication Critical patent/KR101347910B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216Solid or semisolid forms
    • A61K8/022Powders; Compacted Powders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216Solid or semisolid forms
    • A61K8/0229Sticks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/062Oil-in-water emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/064Water-in-oil emulsions, e.g. Water-in-silicone emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • A61Q1/04Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06Lipsticks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • A61Q1/10Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/37Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

본 발명은 생강 초임계 추출물 및 발효 미나리 박 추출물을 유효성분으로 함유하는 화장료 조성물에 관한 것으로, 보다 구체적으로는 생강이 지닌 항알러지 효능을 극대화하기 위하여 생강을 초임계 추출한 추출물과 발효 미나리 박 추출물을 함유함으로써 알러지성 피부질환에 대하여 예방 및 개선 효과가 우수한 화장료 조성물 또는 약학 조성물에 대한 것이다.The present invention relates to a cosmetic composition containing a ginger supercritical extract and a fermented buttercup gourd extract as an active ingredient, and more specifically, to extract a ginger and a supercritical extract of ginger in order to maximize the anti-allergic effect of ginger. The present invention relates to a cosmetic composition or a pharmaceutical composition which is excellent in preventing and improving effects on allergic skin diseases by containing.

Description

생강 초임계 추출물 및 발효 미나리 박 추출물을 함유하는 식품 조성물, 화장료 조성물 및 약학 조성물{a Food Composition, a Cosmetic Composition, a Pharmaceutical Composition Comprising Supercritical Fluid Extract of Ginger and Extract of Dropwort Fermented}A food composition, a cosmetic composition, a pharmaceutical composition comprising a supercritical fluid extract of ginger and extract of dropwort fermented

본 발명은 생강 초임계 추출물 및 발효 미나리 박 추출물을 유효성분으로 함유하는 식품 조성물, 화장료 조성물 및 약학 조성물에 관한 것이다. The present invention relates to a food composition, a cosmetic composition, and a pharmaceutical composition containing a ginger supercritical extract and a fermented parsley extract as an active ingredient.

염증성 피부질환이란 피부 상피 내에 일련의 염증 반응을 일으키는 다양한 자극 요인들로 인해 가려움, 부종, 홍반, 벗겨짐 등과 같은 일련의 임상적 징후와 증상이 유발되는 질환을 말한다.Inflammatory skin diseases are diseases in which a series of clinical signs and symptoms, such as itching, swelling, erythema, peeling, etc., are caused by various stimulating factors causing a series of inflammatory reactions in the skin epithelium.

염증성 피부질환으로는 아토피성 피부염(atopic dermatitis), 접촉성 피부염(contact dermatitis), 지루성 피부염(seborrhoic dermatitis) 및 여드름 등이 알려져 있다. 아토피성 피부염은 일반적으로 습진(eczema)과 같은 의미로 쓰이는데 아토피 체질인 사람에게 생기는 습진 모양의 피부병변으로서 내인성 습진 또는 베니에 양진이라고도 한다. 아토피성 피부염의 원인은 현재까지 밝혀져 있지 않으며 유전적인 경향이 있는 것으로 알려져 있고 현재는 일종의 자가면역 질환이라는 설이 설득력을 얻고 있다. 보통의 습진이나 피부염과는 달리 특이한 증세와 경과를 나타내는데 소아습진의 70~80%가 이에 해당하며 최근 들어 성인에게서도 많이 발생한다.Inflammatory skin diseases include atopic dermatitis, contact dermatitis, seborrhoic dermatitis and acne. Atopic dermatitis is generally used in the same sense as eczema, which is an eczema-like skin lesion that occurs in people with atopic dermatitis. The cause of atopic dermatitis has not been identified to date and is known to have a genetic tendency, and now it is persuaded that it is a kind of autoimmune disease. Unlike normal eczema or dermatitis, it shows unusual symptoms and course, and 70 to 80% of pediatric eczema is present, and it occurs in adults recently.

접촉성 피부염은 외부의 물질에 접촉함으로써 일어나는 피부의 염증이다. 급성습진과 같은 증세를 띠지만, 외부에서 작용하는 특정의 물질에 대한 반응으로서 일어나는 점이 습진과는 다른 점이다.Contact dermatitis is an inflammation of the skin caused by contact with an external substance. It has the same symptoms as acute eczema, but differs from eczema in that it occurs as a response to certain externally acting substances.

지루성 피부염은 머리, 이마, 겨드랑이 등 피지의 분비가 많은 부위에 잘 발생하는 피부염이며 지루성 습진이라고도 한다. 홍반과 가느다란 인설(비듬)이 많이 생기며 20~40대에서 많이 나타난다. 보통의 습진과 달리, 체질이나 피지분비 이상에 의하여 발생되는 질환으로서 햇빛이나 온열에 민감하고, 봄과 가을에 악화하는 일이 많으며, 재발하기 쉬운 특징이 있다.Seborrheic dermatitis is a dermatitis that occurs well in areas with high secretion of sebum, such as the head, forehead and armpits, and is also called seborrheic eczema. A lot of erythema and slender slits (dandruff) occur and appear in many 20s and 40s. Unlike ordinary eczema, the disease is caused by constitution or sebaceous abnormalities, sensitive to sunlight or heat, often worsening in spring and autumn, and easy to recur.

여드름은 모낭 및 피지선에 발생하는 만성 염증성 질환으로서 발생원인은 크게 피지분비의 증가, 혐기성 피부 상재균인 프로피오니박테리움 아크네(Propionibacterium acnes)의 증식이 주원인이라 할 수 있다. 또한 여러 가지 기전이 복합적으로 작용하기도 한다. 여드름이 많이 발생하는 부위의 피지는 남성 호르몬의 일종인 테스토스테론(textosterone)이 5알파-환원효소(5α-reductase)에 의하여 활성형태인 디하이드로테스토스테론(dihydrotestosterone)으로 전환되고, 이 호르몬의 작용으로 피지가 과잉 분비되어 생성된다. 상기에서 생성된 과잉의 피지는 모낭 내에 정체하게 되고 상기 피지가 모낭을 막아 상주하는 혐기성 세균인 프로피오니박테리움 아크네에서 분비되는 지방분해효소와 화학주성인자에 의해 유리지방산 및 각종 저분자 물질들로 전환된다. 이렇게 되면 백혈구가 모낭 주위에 모이고 이들이 모낭벽을 파괴하면 모낭 내용물이 진피 내로 유출되어 염증 반응이 일어나게 된다.Acne is a chronic inflammatory disease of hair follicles and sebaceous glands, the main cause of the increase in sebum secretion, anaerobic skin flora propionibacterium acnes (Propionibacterium acnes) is the main cause. Several mechanisms may also work in combination. Sebum in the acne-prone areas is converted to testosterone (textosterone), a type of male hormone, into dihydrotestosterone, an active form, by 5 alpha-reductase. Is produced by oversecretion. The excess sebum produced above stagnates in the hair follicles and is converted into free fatty acids and various low molecular substances by lipolytic enzymes and chemotactic factors secreted by propionibacterium acne, an anaerobic bacterium that sebum occludes the hair follicles. do. This causes white blood cells to gather around the hair follicles, destroying the hair follicle wall, causing the contents of the hair follicles to leak into the dermis, causing an inflammatory reaction.

현재까지는 상기와 같은 염증성 피부질환의 치료를 위해서 주로 항히스타민제, 비타민 연고, 부신피질호르몬제가 사용되어 왔다. 그러나 이러한 약물은 그 효과가 일시적인 경우가 대부분이고 부작용이 심한 경우도 많다.Until now, antihistamines, vitamin ointments, and corticosteroids have been mainly used for the treatment of inflammatory skin diseases. However, these drugs are often temporary and often have severe side effects.

특히, 아토피성 피부염의 경우에는 여러 종류의 5-리포키시게나제 저해제가 항 알레르기제의 후보 화합물로서 제안되어 왔고, 크로몰린이 알레르겐과 조직 마스트 세포와의 반응을 무효화시키는 작용을 함으로써 증상을 완화하는 것으로 알려져 있으나 상기 물질들도 임상적으로 효과가 뚜렷하지 않는 단점이 있다.In particular, in the case of atopic dermatitis, various 5-lipokishinase inhibitors have been proposed as candidate compounds for antiallergic agents, and chromoline alleviates the reaction of allergens with tissue mast cells. It is known that the above substances also have the disadvantage that the clinical effect is not obvious.

여드름의 치료에는 에리스로마이신 등의 항생제를 이용하거나 여성호르몬인 에스트로젠을 이용한 피지를 조절하는 방법 등이 사용되어 왔으나 부작용이 동반되는 문제점이 있다. 여드름 치료를 위한 화장료에 비타민 A 유도체나 벤조일 퍼옥사이드, 살리실산, 트리클로산 등이 사용되어 왔지만, 이러한 물질들은 어느 정도의 항균 효과는 있으나 피부발적, 피부과민 또는 광과민 등의 부작용을 일으키는 문제점을 지니고 있다.Acne has been used to treat acne by using an antibiotic such as erythromycin or a method of controlling sebum using estrogen, a female hormone, but there are problems associated with side effects. Vitamin A derivatives, benzoyl peroxide, salicylic acid, triclosan and the like have been used in the cosmetics for the treatment of acne, but these substances have some antibacterial effects, but have problems such as skin redness, skin sensitization, or photosensitivity.

이에 본 발명자들은 알러지성 피부질환을 효과적으로 예방하거나 치료할 수 있는 부작용이 없는 조성물을 개발하던 중 생강 초임계 추출물과 발효 미나리 박 추출물이 단일 물질에 비해 알러지성 피부질환을 예방 또는 치료하는 효과까지 현저하게 우수하며 독성을 나타내지 않아 생체에 안전하게 사용될 수 있음을 확인함으로써 본 발명을 완성하였다.Therefore, the inventors of the present invention are developing a composition having no side effects that can effectively prevent or treat allergic skin diseases. Ginger supercritical extract and fermented parsley extract are remarkably effective in preventing or treating allergic skin diseases compared to a single substance. The present invention has been completed by confirming that it can be used safely in a living body because it is excellent and does not exhibit toxicity.

본 발명은 생강 초임계 추출물과 발효 미나리 박 추출물을 유효성분으로 함유함으로써 알러지성 피부질환의 예방 또는 개선용 식품 조성물, 화장료 조성물 또는 약학 조성물을 제공하고자 한다.The present invention is to provide a food composition, cosmetic composition or pharmaceutical composition for the prevention or improvement of allergic skin diseases by containing a ginger supercritical extract and fermented parsley extract as an active ingredient.

이에 본 발명은 바람직한 제1구현예로서, 생강 초임계 추출물 및 발효 미나리 박 추출물을 유효성분으로 함유하는 알러지성 피부질환의 예방 또는 개선용 식품 조성물을 제공한다.Accordingly, the present invention provides a food composition for the prevention or improvement of allergic skin diseases, which comprises a ginger supercritical extract and fermented parsley extract as an active ingredient.

이에 본 발명은 바람직한 제2구현예로서, 생강 초임계 추출물 및 발효 미나리 박 추출물을 유효성분으로 함유하는 알러지성 피부질환의 예방 또는 개선용 화장료 조성물을 제공한다.Accordingly, the present invention provides a cosmetic composition for the prevention or improvement of allergic skin diseases, which comprises a ginger supercritical extract and fermented parsley extract as an active ingredient.

상기 구현예에 의한 화장료 조성물에서, 상기 유효성분의 함량은 0.05중량% 내지 95중량% 범위 내일 수 있다.In the cosmetic composition according to the embodiment, the content of the active ingredient may be in the range of 0.05% to 95% by weight.

상기 구현예에 의한 화장료 조성물에서, 발효 미나리 박 추출물은 생강 초임계 추출물 100 중량부 대비 50 ~ 2000 중량부로 함유될 수 있다.In the cosmetic composition according to the embodiment, the fermented buttercup gourd extract may be contained in an amount of 50 to 2000 parts by weight based on 100 parts by weight of the ginger supercritical extract.

상기 구현예에 의한 화장료 조성물에서, 상기 생강 초임계 추출물은 생강 분말을 초임계 이산화탄소를 이용하여 35~55℃의 온도, 100~400 bar의 압력에서 1~3mL/min의 유속으로 1~3 시간 동안 초임계 추출법으로 추출하여 얻을 수 있다.In the cosmetic composition according to the embodiment, the ginger supercritical extract is a ginger powder using a supercritical carbon dioxide at a temperature of 35 to 55 ° C. and a pressure of 1 to 3 mL / min at a pressure of 100 to 400 bar for 1 to 3 hours. Can be obtained by supercritical extraction.

상기 구현예에 의한 화장료 조성물에서, 상기 발효 미나리 박 추출물은 미나리 40~90중량% 및 당류 10~60중량%을 혼합하고, 15~30℃에서 8~24개월간 발효시킨 후, 발효액을 걸러내고 남은 미나리박을 열수추출함으로써 얻을 수 있다.In the cosmetic composition according to the embodiment, the fermented buttercup gourd extract is mixed with 40 to 90% by weight of parsley and 10 to 60% by weight of sugar, fermented at 15 to 30 ℃ for 8 to 24 months, and then filtered out the fermentation broth It can be obtained by hot water extraction of buttercup foil.

상기 구현예에 의한 화장료 조성물에서, 생강 분말은 평균 입도가 50~500㎛일 수 있다.In the cosmetic composition according to the embodiment, the ginger powder may have an average particle size of 50 ~ 500㎛.

상기 구현예에 의한 화장료 조성물에서, 상기 당류는 흑설탕, 백설탕, 물엿 및 꿀로 이루어진 군에서 선택된 한 가지일 수 있다.In the cosmetic composition according to the embodiment, the sugar may be one selected from the group consisting of brown sugar, white sugar, syrup and honey.

상기 구현예에 의한 화장료 조성물에서, 상기 화장료 조성물의 제형은 화장수, 젤, 수용성 리퀴드, 크림, 에센스, 수중유(O/W)형 및 유중수(W/O)형으로 이루어진 기초화장료 제형; 수중유형 또는 유중수형의 메이크업베이스, 파운데이션, 스킨커버, 립스틱, 립그로스, 페이스파우더, 투웨이케익, 아이섀도, 치크칼라 및 아이브로우펜슬류로 이루어진 색조화장료 제형; 중에서 선택되는 어느 하나일 수 있다.In the cosmetic composition according to the embodiment, the formulation of the cosmetic composition is a basic cosmetic formulation consisting of a lotion, gel, water-soluble liquid, cream, essence, oil-in-water (O / W) type and water-in-oil (W / O) type; Color cosmetic formulations consisting of oil-in-water or water-in-oil makeup bases, foundations, skin covers, lipsticks, lip gloss, face powders, two-way cakes, eye shadows, cheek colors and eyebrow pencils; It may be any one selected from.

본 발명은 바람직한 제3구현예로서, 생강 초임계 추출물 및 발효 미나리 박 추출물을 유효성분으로 함유하는 알러지성 피부질환의 예방 또는 치료용 약학 조성물을 제공한다.As a third preferred embodiment, the present invention provides a pharmaceutical composition for preventing or treating allergic skin diseases, which comprises a ginger supercritical extract and a fermented parsley extract as an active ingredient.

삭제delete

삭제delete

삭제delete

상기 구현예에 의한 알러지성 피부질환의 예방 또는 치료용 약학 조성물의 제형은, 경고제(PLASTERS), 로션제(LPTIONS), 리니멘트제(LINIMENTS), 액제(LIQUIDS AND SOLUTIONS), 에어로솔제(AEROSOLS), 엑스제(EXTRACTS), 연고제(OINTMENTS), 유동엑스제(FLUIDEXTRACTS), 유제(EMULSIONS), 현탁제(SUSPENSIONS), 캅셀제(CAPSULES), 크림제(CREAMS), 연질 또는 경질 젤라틴 캄셀, 첩부제, 서방화제제 중 선택된 어느 하나일 수 있다.Formulation of the pharmaceutical composition for the prevention or treatment of allergic skin diseases according to the embodiment, PLASTERS, lotion (LPTIONS), linings (LINIMENTS), liquid (LIQUIDS AND SOLUTIONS), aerosol (AEROSOLS) ), EXTRACTS, Ointments, FLUIDEXTRACTS, Emulsions, Emulsions, SUSPENSIONS, CAPSULES, CREAMS, Soft or hard gelatin It may be any one selected from a sustained release agent.

본 발명은 생강이 지닌 항알러지 효능을 극대화하기 위하여 생강을 초임계 추출한 추출물과 발효 미나리 박 추출물을 함유함으로써 알러지성 피부질환에 대하여 예방 및 개선 효과가 우수한 식품 조성물, 화장료 조성물 또는 약학 조성물을 제공할 수 있다.The present invention provides a food composition, cosmetic composition or pharmaceutical composition excellent in the prevention and improvement effect against allergic skin diseases by containing a supercritical extract of ginger and fermented parsley extract in order to maximize the anti-allergic effect of ginger. Can be.

도 1은 본 발명의 바람직한 일 실험예에 따른 생강 초임계 추출물의 β-hexosaminidase 방출 억제능을 나타내는 그래프이다.
도 2는 본 발명의 바람직한 일 실험예에 따른 생강 초임계 추출물의 세포독성을 나타내는 그래프이다.
도 3은 본 발명의 바람직한 일 실험예에 따른 발효 미나리 박 추출물의 β-hexosaminidase 방출 억제능을 나타내는 그래프이다.
도 4는 본 발명의 바람직한 일 실험예에 따른 발효 미나리 박 추출물의 세포독성을 나타내는 그래프이다.
도 5는 본 발명의 바람직한 일 실시예에 따른 생강 초임계 추출물과 발효 미나리 박 추출물을 함유하는 조성물의 β-hexosaminidase 방출 억제능(항알레르기성)을 나타내는 그래프이다.
Figure 1 is a graph showing the β-hexosaminidase release inhibitory ability of the ginger supercritical extract according to an embodiment of the present invention.
Figure 2 is a graph showing the cytotoxicity of the ginger supercritical extract according to a preferred experimental example of the present invention.
Figure 3 is a graph showing the β-hexosaminidase release inhibition ability of the fermented buttercup gourd extract according to an experimental example of the present invention.
Figure 4 is a graph showing the cytotoxicity of the fermented buttercup gourd extract according to an embodiment of the present invention.
FIG. 5 is a graph showing β-hexosaminidase release inhibitory ability (antiallergic) of a composition containing a ginger supercritical extract and a fermented parsley extract according to an embodiment of the present invention.

이하, 본 발명을 더욱 상세히 설명한다.Hereinafter, the present invention will be described in more detail.

우선, 본 발명은 생강 초임계 추출물 및 발효 미나리 박 추출물을 유효성분으로 함유함으로써 알러지성 피부질환의 예방 및 개선용 식품 조성물을 제공한다. 본 발명의 생강 초임계 추출물과 발효 미나리 박 추출물을 함유하는 식품 조성물은 높은 항알러지 효과를 지니고 있을 뿐 아니라 독성 효과가 없으므로 알러지성 피부질환의 예방 및 개선용으로 매우 적합하다. 상기한 식품 조성물은 차, 음료, 건강 보조식품, 캡슐 등의 형태로 이용될 수 있다.First, the present invention provides a food composition for the prevention and improvement of allergic skin diseases by containing ginger supercritical extract and fermented parsley extract as an active ingredient. The food composition containing the ginger supercritical extract and fermented parsley extract of the present invention not only has a high anti-allergic effect but also no toxic effect, which is very suitable for the prevention and improvement of allergic skin diseases. The food composition may be used in the form of tea, beverages, dietary supplements, capsules and the like.

또한, 본 발명은 생강 초임계 추출물 및 발효 미나리 박 추출물을 유효성분으로 함유하는 알러지성 피부질환의 예방 및 개선용 화장료 조성물을 제공한다. 이때, 유효성분의 함량은 조성물 총 중량 대비 0.05~95중량% 범위 내인 것이 바람직하다. 그리고, 상기 조성물 중 발효 미나리 박 추출물은 생강 초임계 추출물의 100 중량부 대비 50 ~ 2000 중량부로 함유되는 것이 항알러지 효과가 높으므로 바람직하다.The present invention also provides a cosmetic composition for the prevention and improvement of allergic skin diseases containing ginger supercritical extract and fermented parsley extract as an active ingredient. At this time, the content of the active ingredient is preferably in the range 0.05 ~ 95% by weight relative to the total weight of the composition. In addition, the fermented buttercup gourd extract in the composition is preferably contained at 50 to 2000 parts by weight relative to 100 parts by weight of the ginger supercritical extract because the anti-allergic effect is high.

상기 생강 초임계 추출물은 생강 분말을 초임계 이산화탄소를 이용하여 35~55℃의 온도, 100~400 bar의 압력에서 1~3mL/min의 유속으로 1~3 시간 동안 초임계 추출법으로 추출하여 얻는 것이, 생강 특유의 맛과 향기를 제거하거나 보완할 수 있을 뿐 아니라 짧은 시간 안에 추출 수율이 높으면서도 진저롤(gingerol)의 함량이 높은 추출물을 얻을 수 있으므로 바람직하다. 상기 각각의 조건들이 범위를 벗어날 경우, 추출 수율이 낮아지거나 추출 수율이 더 이상 증가하지 않아 경제적으로 바람직하지 못하다.The ginger supercritical extract is obtained by extracting ginger powder by supercritical extraction for 1 to 3 hours at a flow rate of 1 to 3 mL / min at a temperature of 35 to 55 ° C. and a pressure of 100 to 400 bar using supercritical carbon dioxide. In addition to removing or supplementing the flavor and flavor peculiar to ginger, it is preferable to obtain an extract with a high extraction yield and a high content of gingerol in a short time. If the respective conditions are out of range, the extraction yield is lowered or the extraction yield is no longer increased, which is economically undesirable.

그리고, 상기 생강 초임계 추출물 제조방법에서 생강 분말은 평균입도가50~500 ㎛인 것이 추출 속도가 높으므로 바람직하다. In the ginger supercritical extract manufacturing method, the ginger powder has an average particle size of 50 to 500 μm, and thus the extraction speed is high.

상기 방법으로 생강을 초임계 추출하면 짧은 시간 안에 2.5~3.0중량%의 수율로 생강유(생강 초임계 추출물)를 얻을 수 있다.Supercritical extraction of ginger by the above method can obtain ginger oil (ginger supercritical extract) in a yield of 2.5 to 3.0% by weight in a short time.

그리고, 상기 추출방법에 의하면 항알러지 활성성분 중 하나인 진저롤(gingerol)의 함량이 21~25중량%인 생강 초임계 추출물을 얻을 수 있다. In addition, according to the extraction method, the ginger supercritical extract having a content of 21 to 25% by weight of gingerol, which is one of the anti-allergic active ingredients, can be obtained.

상기 발효 미나리 박 추출물은 미나리 40~90중량% 및 당류 10~60중량%을 혼합하고, 15~30℃에서 8~24개월간 발효시킨 후, 발효액을 걸러내고 남은 미나리박(부산물)을 열수추출함으로써 얻을 수 있다. 발효 미나리 박을 열수추출한 후에 필요에 따라 농축 및 동결건조 과정을 더 거칠 수 있다. 상기한 방법에 따르면 평균 15~25%의 높은 수율로 발효 미나리 박 추출물을 얻을 수 있다.The fermented buttercup gourd extract is mixed with 40 to 90% by weight of parsley and 10 to 60% by weight of sugar, fermented at 15 to 30 ℃ for 8 to 24 months, and then by filtering the fermentation broth and extracting the remaining buttercup (by-product) by hot water You can get it. After hydrothermal extraction of the fermented buttercup gourd may be further subjected to concentration and lyophilization as necessary. According to the above method, the fermented buttercup gourd extract can be obtained with a high yield of 15-25% on average.

상기 발효 미나리 박 추출물 제조과정에서, 당류는 흑설탕, 백설탕, 물엿 및 꿀로 이루어진 군에서 선택된 한 가지 이상일 수 있다.In the fermented buttercup gourd extract manufacturing process, the sugar may be one or more selected from the group consisting of brown sugar, white sugar, starch syrup and honey.

상기한 생강 초임계 추출물 및 발효 미나리 박 추출물은 각각 항알러지 효능을 지니고 있지만 상기 두 물질이 혼합된 경우 더욱 증대된 항알러지 효능을 나타낼 수 있다.The ginger supercritical extract and the fermented buttercup gourd extract have antiallergic efficacy, respectively, but may show an increased antiallergic effect when the two substances are mixed.

상기 화장료 조성물의 제형은 화장수, 젤, 수용성 리퀴드, 크림, 에센스, 수중유(O/W)형 및 유중수(W/O)형으로 이루어진 기초화장료 제형; 수중유형 또는 유중수형의 메이크업베이스, 파운데이션, 스킨커버, 립스틱, 립그로스, 페이스파우더, 투웨이케익, 아이섀도, 치크칼라 및 아이브로우펜슬류로 이루어진 색조화장료 제형; 중에서 선택되는 어느 하나일 수 있다.
Formulation of the cosmetic composition is a cosmetic composition consisting of a lotion, gel, water-soluble liquid, cream, essence, oil-in-water (O / W) type and water-in-oil (W / O) type; Color cosmetic formulations consisting of oil-in-water or water-in-oil makeup bases, foundations, skin covers, lipsticks, lip gloss, face powders, two-way cakes, eye shadows, cheek colors and eyebrow pencils; It may be any one selected from.

다음으로, 본 발명은 생강 초임계 추출물 및 발효 미나리 박 추출물을 유효성분으로 함유함으로써 알러지성 피부질환의 예방 및 치료용 약학 조성물을 제공한다. 본 발명의 생강 초임계 추출물과 발효 미나리 박 추출물을 함유하는 약학 조성물은 높은 항알러지 효과를 지니고 있을 뿐 아니라 독성 효과가 없으므로 알러지성 피부질환의 예방 및 치료용으로 매우 적합하다.Next, the present invention provides a pharmaceutical composition for the prevention and treatment of allergic skin diseases by containing a ginger supercritical extract and fermented parsley extract as an active ingredient. The pharmaceutical composition containing the ginger supercritical extract and fermented parsley extract of the present invention has not only a high anti-allergic effect but also no toxic effect, which is very suitable for the prevention and treatment of allergic skin diseases.

약학 조성물의 제형은 경고제(PLASTERS), 로션제(LPTIONS), 리니멘트제(LINIMENTS), 액제(LIQUIDS AND SOLUTIONS), 에어로솔제(AEROSOLS), 엑스제(EXTRACTS), 연고제(OINTMENTS), 유동엑스제(FLUIDEXTRACTS), 유제(EMULSIONS), 현탁제(SUSPENSIONS), 캅셀제(CAPSULES), 크림제(CREAMS), 연질 또는 경질 젤라틴 캄셀, 첩부제, 서방화제제 중 선택된 어느 하나일 수 있다.
Formulations of pharmaceutical compositions include PLASTERS, LOTIONS, LINIMENTS, LIQUIDS AND SOLUTIONS, AEROSOLS, EXTRACTS, OINTMENTS, Fluid X FLUIDEXTRACTS, EMULSIONS, SUSPENSIONS, CAPSULES, CREAMS, soft or hard gelatin campels, patches, sustained release agents.

이하, 본 발명의 구성을 실시예를 통하여 보다 상세히 설명하나, 본 발명의 범위가 하기 실시예로 한정되는 것은 아니다.
Hereinafter, the configuration of the present invention in more detail through examples, but the scope of the present invention is not limited to the following examples.

[실시예][Example]

생강 ginger 초임계Supercritical 추출물의 제조 Preparation of extract

초임계유체추출장치(SFT-100XW, Supercritical Fluid Technologies, Inc., Newark, DE, USA)를 사용하였고, 평균입도가 50 ~ 500 ㎛인 생강 분말 18g을 100 mL의 용량의 추출조에 넣어 추출하였다. 시료의 추출조건은 35, 45, 55℃온도에서 100, 200, 300, 400 bar로 압력을 변화시키며 실시하였고, 이산화탄소의 유속은 2 mL/min로 다이나믹 모드에서 2시간동안 추출하여 추출물을 곧바로 용기(vial)에 받아내었다.A supercritical fluid extractor (SFT-100XW, Supercritical Fluid Technologies, Inc., Newark, DE, USA) was used, and 18 g of ginger powder having an average particle size of 50 to 500 μm was extracted into an extraction tank having a volume of 100 mL. The extraction conditions of the samples were carried out with varying pressure at 35, 45, 55 ℃ temperature to 100, 200, 300, 400 bar, the flow rate of carbon dioxide is 2 mL / min for 2 hours in the dynamic mode to extract the container immediately I received it in (vial).

발효 미나리 박 추출물의 제조Preparation of Fermented Buttercup Gourd Extract

대구 비슬산 가창면 정대리에서 수확한 청정미나리를 수세한 후 세척 및 살균된 옹기에 넣고 흑설탕(brown sugar)을 1:1의 중량비로 혼합한 후, 상온(15~25℃)에서 1년간 방치, 자연발효가 일어나도록 하여 미나리 발효액을 제조하였다. 그리고, 발효 후 남은 잔여 부산물(미나리박) 1kg을 수세하고 8L의 물을 가하여 2시간 열수 추출, 농축, 동결 건조하여 192.8g(19.3%의 수율)의 발효 미나리 박 추출물을 제조하였다.Wash the clean parsley harvested from Jeongdae-ri, Gachang-myeon, Daegu, Bisulsan, wash and sterilize, and mix brown sugar in a weight ratio of 1: 1, and leave it at room temperature (15 ~ 25 ℃) for 1 year Was produced to prepare a buttercup fermentation broth. Then, 1kg of the remaining by-products (minaribak) remaining after fermentation were washed with water and 8L of water was added thereto for 2 hours, followed by hot water extraction, concentration, and lyophilization to prepare 192.8g (19.3% yield) of fermented buttercup meal.

생강 ginger 초임계Supercritical 추출물 및 발효 미나리 박 추출물 함유 조성물 제조 Extract and Fermented Buttercup Extract Containing Composition Preparation

상기 제조된 생강 초임계 추출물 100㎍/mL과 상기 제조된 발효 미나리 박 추출물 1000㎍/mL 을 혼합하여 본 발명의 조성물을 제조하였다.
The composition of the present invention was prepared by mixing 100 μg / mL of the prepared ginger supercritical extract and 1000 μg / mL of the fermented buttercup extract.

[실험방법][Experimental Method]

1. 세포주 배양 1. Cell line culture

대식세포 계열(murine macrophage cell line)인 RAW264.7 세포주는 한국 세포주 은행(KCLB, Seoul, Korea)으로부터 분양받았으며, 10% FBS(fetal bovine serum)와 1% antibiotics(penicillin/ streptomycin)를 첨가한 DMEM 배지를 이용하여 5% CO2가 존재하는 37℃ incubator에서 1주일에 2~3회 계대 배양하였다.RAW264.7 cell line, a murine macrophage cell line, was distributed from Korea Cell Line Bank (KCLB, Seoul, Korea), and DMEM added 10% FBS (fetal bovine serum) and 1% antibiotics (penicillin / streptomycin). The medium was passaged 2-3 times a week in a 37 ℃ incubator containing 5% CO 2 .

Rat 유래의 비만세포(RBL-2H3)에 대한 세포독성은 MTT 법으로 측정하였다. 본 실험에 사용한 세포주 RBL-2H3 cell은 한국 세포주 은행(Seoul, Korea)을 통해서 분양 받아 계대배양하면서 실험하였다. 세포배양에 사용된 배지는 10% FBS(fetal bovine serum)와 1% antibiotics(penicillin/streptomycin)를 첨가한 MEM 배지를 이용하여 37℃에서 5% CO2 incubator에서 2~3일간 배양한 후 사용하였다.
Cytotoxicity against mast cells (RBL-2H3) derived from rats was measured by MTT method. The cell line RBL-2H3 cells used in this experiment were tested by subcultured through the pre-cultured through the Korea Cell Line Bank (Seoul, Korea). The medium used for cell culture was 5% CO 2 at 37 ° C using MEM medium containing 10% FBS (fetal bovine serum) and 1% antibiotics (penicillin / streptomycin). It was used after incubating in incubator for 2-3 days.

2. β-Hexosaminidase 방출 억제능 측정 2. Measurement of β- Hexosaminidase Release Inhibition

비만세포주 RBL-2H3을 1ml(2 x 105 cells, 24 well plate)에 anti-DNP IgE(0.45㎍/ml)로 16시간 감작시키고, DNP-BSA(10㎍/mL)로 활성화시키기 전에 30분 동안 37℃에서 농도별 시료를 20ml 처리하였다. 반응이 끝난 후 4℃에서 10분간 400xg에서 원침하여 얻은 상등액 25㎕를 기질 p-nitrophenyl-N-acetyl-b-D-glucosaminide 25㎕와 37℃에서 1시간 반응시킨 후 stop solution(0.1 M NaCO/NaHCO, pH 10) 200㎕를 가하여 정지시키고 405 nm에서 흡광도를 측정하여 b-hexosaminidase의 양을 계산하였다.
The mast cell line RBL-2H3 was sensitized in 1 ml (2 x 10 5 cells, 24 well plates) with anti-DNP IgE (0.45 µg / ml) for 16 hours and 30 minutes before activation with DNP-BSA (10 µg / mL). 20 ml of the sample for each concentration was treated at 37 ℃. After the reaction, 25 μl of the supernatant obtained by centrifugation at 400 × g for 10 minutes at 4 ° C. was reacted with 25 μl of substrate p-nitrophenyl-N-acetyl-bD-glucosaminide at 37 ° C. for 1 hour, followed by stop solution (0.1 M NaCO / NaHCO, pH 10) 200 μl was added to stop and the absorbance was measured at 405 nm to calculate the amount of b-hexosaminidase.

[실험예][Experimental Example]

실험예 1: 생강 초임계 추출물(생강 오일)의 세포 독성 및 β-hexosaminidase 방출 억제능 측정 Experimental Example 1 Measurement of Cytotoxicity and Inhibition of β- hexosaminidase Release of Ginger Supercritical Extract (Ginger Oil)

RBL-2H3 세포에 대한 생강 초임계 추출물의 독성 및 항원에 의한 비만세포 탈과립에 대한 억제 효과(β-hexosaminidase 방출 억제능)를 테스트한 결과, 테스트한 농도 구간에서 세포 독성은 없었으며, 농도 의존적으로 비만 세포 탈과립을 억제하는 효과를 나타내었다(도 1 및 도 2).
Testing of the toxicity of Ginger supercritical extract against RBL-2H3 cells and the inhibitory effect of antigen-induced mast cell degranulation (β-hexosaminidase release inhibitory ability) showed no cytotoxicity in the tested concentration range, and was concentration-dependent obesity. The effect of inhibiting cell degranulation was shown (FIGS. 1 and 2).

실험예 2: 발효 미나리 박 추출물의 세포 독성 및 β-hexosaminidase 방출 억제능 측정Experimental Example 2: Measurement of Cytotoxicity and β-hexosaminidase Release Inhibition of Fermented Buttercup Extract

발효 후 부산물인 미나리 박의 열수 추출물이 비만세포 탈과립(β-hexosaminidase 방출 억제능)을 유의적으로 억제하는 효과가 있음을 나타내었으며, 세포 독성은 나타나지 않았다(도 3 및 도 4)
After fermentation, the hot water extract of Buttercup, a by-product, was found to have an effect of significantly inhibiting mast cell degranulation (β-hexosaminidase release inhibitory ability), and no cytotoxicity was observed (FIGS. 3 and 4).

실험예 3: 생강 초임계 추출물과 발효 미나리 박 추출물의 혼합물의 세포 독성 및 β-hexosaminidase 방출 억제능(항알레르기) 측정Experimental Example 3: Determination of Cytotoxicity and β-hexosaminidase Release Inhibition (Antiallergic) of a Mixture of Ginger Supercritical Extract and Fermented Buttercup Extract

생강 초임계 추출물과 발효 미나리 박 추출물의 혼합물이 각각의 단일 물질에 비해 더 효과가 있음을 알아보기 위해, 각각 독성이 없는 농도 구간에서 혼합하여 비만세포 활성화(β-hexosaminidase 방출 억제능)에 대한 효과를 측정한 결과, 생강 초임계 추출물은 100㎍/mL에서 33%의 억제활성을 나타내었고(도 1), 발효 미나리 박 추출물은 1000㎍/mL에서 76%의 억제활성을 나타내었으며(도 3), 이 두 물질을 혼합한 혼합액의 경우에는 89%의 억제활성을 나타내어 억제 효과의 시너지 효과를 확인할 수 있었다(도 5).
To find out that the mixture of ginger supercritical extract and fermented parsley extract is more effective than each single substance, they are mixed in non-toxic concentration sections, respectively, to effect the effect on the activation of mast cells (β-hexosaminidase release inhibitory ability). As a result, the ginger supercritical extract showed 33% of inhibitory activity at 100µg / mL (Fig. 1), and the fermented buttercup extract showed 76% of inhibitory activity at 1000µg / mL (Figure 3). In the mixed solution of these two substances, the inhibitory activity was 89%, confirming the synergistic effect of the inhibitory effect (FIG. 5).

이상 살펴본 바와 같이 본 발명의 생강 초임계 추출물 및 발효 미나리 박 추출물을 함유하는 조성물은 각각의 단일 물질만을 사용하는 경우보다 피부 개선 효과가 우수하다는 것을 알 수 있다.
As described above, the composition containing the ginger supercritical extract and the fermented parsley extract of the present invention can be seen that the skin improvement effect is superior to the case of using only each single substance.

[제조예][Manufacturing Example]

하기와 같이, 실시예 1에서 수득한 생강 초임계 추출물과 발효 미나리 박 추출물을 함유한 영양 크림, 미스트 및 바디 워시 등의 화장료 조성물을 통상의 방법에 따라 제조하였다.
As described below, cosmetic compositions such as nourishing cream, mist and body wash containing the ginger supercritical extract obtained in Example 1 and the fermented parsley extract were prepared according to a conventional method.

제조예Manufacturing example 1: 크림 1: Cream

성분ingredient 함량(%)content(%) 비고Remarks 정제수Purified water 71.3971.39 SolventSolvent Isoamyl LaurateIsoamyl laurate 8.08.0 Skin conditioning agentSkin conditioning agent Butylene GlycolButylene glycol 5.05.0 Skin conditioning agentSkin conditioning agent GlycerinGlycerin 5.05.0 Skin conditioning agentSkin conditioning agent Glyceryl StearateGlyceryl Stearate 4.04.0 Surfactant-Emulsifying AgentSurfactant-Emulsifying Agent Cetearyl AlcoholCetearyl Alcohol 2.02.0 Emusion StabilizerEmusion Stabilizer Caprylyl glycolCaprylyl glycol 0.30.3 Skin conditioning agentSkin conditioning agent Caprylhydroxamic acidCaprylhydroxamic acid 0.10.1 Chelating AgentChelating Agent 생강 초임계 추출물Ginger Supercritical Extract 0.060.06 생강 초임계 추출, 항알러지 효과Ginger supercritical extract, anti-allergic effect 발효 미나리 박 추출물Fermented Buttercup Gourd Extract 1.81.8 미나리 당발효 추출, 항알러지 효과Buttercup sugar extract, anti-allergic effect 혼합추출물
(홍삼, 사철쑥꽃, 형개, 회향, 서양측백나무잎)
Mixed extract
(Red ginseng, evergreen mugwort, hedgehog, fennel, cypress leaves)
1.21.2 Skin conditioning agentSkin conditioning agent
동백오일Camellia oil 1.01.0 Skin conditioning agentSkin conditioning agent 향료Spices 0.150.15 --

제조예Manufacturing example 2:  2: 미스트mist

성분ingredient 함량(%)content(%) 비고Remarks 정제수Purified water 67.4867.48 SolventSolvent Butylene GlycolButylene glycol 2.52.5 Skin conditioning agentSkin conditioning agent GlycerinGlycerin 3.03.0 Skin conditioning agentSkin conditioning agent 에탄올ethanol 16.016.0 SolventSolvent CyclodextrinCyclodextrin 0.10.1 AbsorbentAbsorbent Caprylyl glycolCaprylyl glycol 0.40.4 Skin conditioning agentSkin conditioning agent Caprylhydroxamic acidCaprylhydroxamic acid 0.10.1 Chelating AgentChelating Agent 생강 초임계 추출물Ginger Supercritical Extract 0.020.02 생강 초임계 추출, 항알러지 효과Ginger supercritical extract, anti-allergic effect 발효 미나리 박 추출물Fermented Buttercup Gourd Extract 1.51.5 미나리 당발효 추출, 항알러지 효과Buttercup sugar extract, anti-allergic effect 혼합추출물
(홍삼, 사철쑥꽃, 형개, 회향, 서양측백나무잎)
Mixed extract
(Red ginseng, evergreen mugwort, hedgehog, fennel, cypress leaves)
8.08.0 Skin conditioning agentSkin conditioning agent
Tocopheryl AcetateTocopheryl Acetate 0.10.1 Skin conditioning agent, 비타민 E 유도체Skin conditioning agent, vitamin E derivative NiacinamideNiacinamide 0.30.3 Skin conditioning agent, Vitamin B3Skin conditioning agent, Vitamin B3 Copper Tripeptide-1Copper Tripeptide-1 0.30.3 Skin conditioning agentSkin conditioning agent ArginineArginine 0.20.2 Skin conditioning agent, 아미노산Skin conditioning agent, amino acids

제조예Manufacturing example 3:  3: 바디body 워시Wash

성분ingredient 함량(%)content(%) 비고Remarks 정제수Purified water 64.7864.78 SolventSolvent Sodium Laureth SulfateSodium Laureth Sulfate 15.015.0 Surfactant-Cleansing AgentSurfactant-Cleansing Agent Lauryl GlucosideLauryl glucoside 6.06.0 Surfactant-Cleansing AgentSurfactant-Cleansing Agent Cocamidopropyl BetaineCocamidopropyl Betaine 6.06.0 Surfactant-Cleansing AgentSurfactant-Cleansing Agent Caprylyl glycolCaprylyl glycol 0.40.4 Skin conditioning agentSkin conditioning agent Caprylhydroxamic acidCaprylhydroxamic acid 0.10.1 Chelating AgentChelating Agent 생강 초임계 추출물Ginger Supercritical Extract 0.020.02 생강 초임계 추출, 항알러지 효과Ginger supercritical extract, anti-allergic effect 발효 미나리 박 추출물Fermented Buttercup Gourd Extract 1.51.5 미나리 당발효 추출, 항알러지 효과Buttercup sugar extract, anti-allergic effect 혼합추출물
(홍삼, 사철쑥꽃, 형개, 회향, 서양측백나무잎)
Mixed extract
(Red ginseng, evergreen mugwort, hedgehog, fennel, cypress leaves)
5.05.0 Skin conditioning agentSkin conditioning agent
Laurdimonium Hydroxypropyl
Hydrolyzed Wheat Protein
Laurdimonium Hydroxypropyl
Hydrolyzed Wheat Protein
0.50.5 Antistatic agentAntistatic agent
향료Spices 0.70.7 --

이상에서 본 발명의 바람직한 실시예, 실험예 및 제조예에 대하여 도시하고 또한 설명하였으나, 본 발명은 상기한 실시예 또는 제조예에 한정되지 않고, 이하 청구범위에서 청구하는 본 발명의 요지를 벗어남이 없이 당해 발명의 분야에서 통상의 지식을 가진 자라면 누구든지 다양한 변형실시가 가능함은 물론이며, 그와 같은 변형은 청구범위의 기재 범위 내에 있게 된다.
Although preferred embodiments, experimental examples, and preparations of the present invention have been shown and described above, the present invention is not limited to the above-described examples or preparations, but deviates from the gist of the present invention as claimed in the following claims. Without departing from the scope of the present invention, it will be apparent to those skilled in the art that various modifications can be made without departing from the scope of the claims.

Claims (14)

생강 초임계 추출물 및 발효 미나리 박 추출물을 유효성분으로 함유하는 알러지성 피부질환의 예방 또는 개선용 식품 조성물.Food composition for the prevention or improvement of allergic skin diseases containing ginger supercritical extract and fermented parsley extract as an active ingredient. 생강 초임계 추출물 및 발효 미나리 박 추출물을 유효성분으로 함유하는 알러지성 피부질환의 예방 또는 개선용 화장료 조성물.Cosmetic composition for the prevention or improvement of allergic skin diseases containing ginger supercritical extract and fermented parsley extract as an active ingredient. 제2항에 있어서,
상기 유효성분의 함량은 0.05중량% 내지 95중량%인 것을 특징으로 하는 화장료 조성물.
3. The method of claim 2,
The content of the active ingredient is a cosmetic composition, characterized in that 0.05% to 95% by weight.
제2항에 있어서,
발효 미나리 박 추출물은 생강 초임계 추출물 100 중량부 대비 50 ~ 2000 중량부로 함유된 것인 화장료 조성물.
3. The method of claim 2,
Fermented buttercup gourd extract is a cosmetic composition containing 50 to 2000 parts by weight relative to 100 parts by weight of ginger supercritical extract.
제2항에 있어서,
상기 생강 초임계 추출물은 생강 분말을 초임계 이산화탄소를 이용하여 35~55℃의 온도, 100~400 bar의 압력에서 1~3mL/min의 유속으로 1~3 시간 동안 초임계 추출법으로 추출하여 얻은 것을 특징으로 하는 화장료 조성물.
3. The method of claim 2,
The ginger supercritical extract was obtained by extracting ginger powder by supercritical extraction for 1 to 3 hours at a flow rate of 1 to 3 mL / min at a temperature of 35 to 55 ° C. and a pressure of 100 to 400 bar using supercritical carbon dioxide. Cosmetic composition characterized in that.
제2항에 있어서,
상기 발효 미나리 박 추출물은 미나리 40~90중량% 및 당류 10~60중량%을 혼합하고, 15~30℃에서 8~24개월간 발효시킨 후, 발효액을 걸러내고 남은 미나리박을 열수추출함으로써 얻어지는 것을 특징으로 하는 화장료 조성물.
3. The method of claim 2,
The fermented buttercup gourd extract is obtained by mixing 40 to 90% by weight of parsley and 10 to 60% by weight of sugar, fermenting at 15 to 30 ° C. for 8 to 24 months, filtering the fermentation broth, and extracting the remaining parsley. Cosmetic composition to be.
제5항에 있어서,
생강 분말은 평균 입도가 50~500㎛인 화장료 조성물.
The method of claim 5,
Ginger powder is a cosmetic composition having an average particle size of 50 ~ 500㎛.
제6항에 있어서,
상기 당류는 흑설탕, 백설탕, 물엿 및 꿀로 이루어진 군에서 선택된 한 가지 이상인 것을 특징으로 하는 화장료 조성물.
The method according to claim 6,
The sugar is a cosmetic composition, characterized in that at least one selected from the group consisting of brown sugar, white sugar, starch syrup and honey.
제2항 내지 제8항 중 어느 한 항에 있어서,
상기 화장료 조성물의 제형은 화장수, 젤, 수용성 리퀴드, 크림, 에센스, 수중유(O/W)형 및 유중수(W/O)형으로 이루어진 기초화장료 제형; 수중유형 또는 유중수형의 메이크업베이스, 파운데이션, 스킨커버, 립스틱, 립그로스, 페이스파우더, 투웨이케익, 아이섀도, 치크칼라 및 아이브로우펜슬류로 이루어진 색조화장료 제형; 중에서 선택되는 어느 하나인 것을 특징으로 하는 화장료 조성물.
9. The method according to any one of claims 2 to 8,
Formulation of the cosmetic composition is a cosmetic composition consisting of a lotion, gel, water-soluble liquid, cream, essence, oil-in-water (O / W) type and water-in-oil (W / O) type; Color cosmetic formulations consisting of oil-in-water or water-in-oil makeup bases, foundations, skin covers, lipsticks, lip gloss, face powders, two-way cakes, eye shadows, cheek colors and eyebrow pencils; Cosmetic composition, characterized in that any one selected from.
삭제delete 삭제delete 삭제delete 생강 초임계 추출물 및 발효 미나리 박 추출물을 유효성분으로 함유하는 알러지성 피부질환의 예방 또는 치료용 약학 조성물.A pharmaceutical composition for the prophylaxis or treatment of allergic skin diseases, comprising a ginger supercritical extract and fermented parsley extract as an active ingredient. 제13항에 있어서,
약학 조성물의 제형은 경고제(PLASTERS), 로션제(LPTIONS), 리니멘트제(LINIMENTS), 액제(LIQUIDS AND SOLUTIONS), 에어로솔제(AEROSOLS), 엑스제(EXTRACTS), 연고제(OINTMENTS), 유동엑스제(FLUIDEXTRACTS), 유제(EMULSIONS), 현탁제(SUSPENSIONS), 캅셀제(CAPSULES), 크림제(CREAMS), 연질 또는 경질 젤라틴 캄셀, 첩부제, 서방화제제 중 선택된 어느 하나인 것을 특징으로 하는 알러지성 피부질환의 예방 또는 치료용 약학 조성물.
The method of claim 13,
Formulations of pharmaceutical compositions include PLASTERS, LOTIONS, LINIMENTS, LIQUIDS AND SOLUTIONS, AEROSOLS, EXTRACTS, OINTMENTS, Fluid X Allergy, characterized in that any one selected from (FLUIDEXTRACTS), emulsion (EMULSIONS), suspending agent (SUSPENSIONS), capsules (CAPSULES), creams (CREAMS), soft or hard gelatin campel, patch, sustained-release agent Pharmaceutical compositions for the prevention or treatment of skin diseases.
KR1020120010048A 2012-01-31 2012-01-31 a Food Composition, a Cosmetic Composition, a Pharmaceutical Composition Comprising Supercritical Fluid Extract of Ginger and Extract of Dropwort Fermented KR101347910B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020120010048A KR101347910B1 (en) 2012-01-31 2012-01-31 a Food Composition, a Cosmetic Composition, a Pharmaceutical Composition Comprising Supercritical Fluid Extract of Ginger and Extract of Dropwort Fermented
PCT/KR2012/008252 WO2013115456A1 (en) 2012-01-31 2012-10-11 Food, cosmetic material, or pharmaceutical composition containing ginger supercritical extract and fermented dropwort residue extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020120010048A KR101347910B1 (en) 2012-01-31 2012-01-31 a Food Composition, a Cosmetic Composition, a Pharmaceutical Composition Comprising Supercritical Fluid Extract of Ginger and Extract of Dropwort Fermented

Publications (2)

Publication Number Publication Date
KR20130088665A KR20130088665A (en) 2013-08-08
KR101347910B1 true KR101347910B1 (en) 2014-01-08

Family

ID=48905464

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020120010048A KR101347910B1 (en) 2012-01-31 2012-01-31 a Food Composition, a Cosmetic Composition, a Pharmaceutical Composition Comprising Supercritical Fluid Extract of Ginger and Extract of Dropwort Fermented

Country Status (2)

Country Link
KR (1) KR101347910B1 (en)
WO (1) WO2013115456A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240036213A (en) 2022-09-13 2024-03-20 위즈티앤티 주식회사 Baby bottom cleanser composition Composition comprising ginger and herbal extract for anti-bacteria
KR20240036214A (en) 2022-09-13 2024-03-20 위즈티앤티 주식회사 Cleaning composition for girl comprising ginger and complex extract having anti-fungi

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10086033B2 (en) 2013-12-24 2018-10-02 Innovative Herbal Products (Aust) Pty Ltd Treatment of pain
US11123272B2 (en) 2016-12-02 2021-09-21 Symrise Ag Cosmetic blends

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002047195A (en) 2000-07-12 2002-02-12 Pharmaceutical Industry Technology & Development Center Method for producing extract containing active ingredient of ginger and pharmaceutical composition comprising the same extract

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002047195A (en) 2000-07-12 2002-02-12 Pharmaceutical Industry Technology & Development Center Method for producing extract containing active ingredient of ginger and pharmaceutical composition comprising the same extract

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
O.R. Justo et al. "Anti Inflammatory Effects Of Ginger And Rosemary Extracts Obtained By Supercritical Fluid Technology", In: 11th European Meeting on Supercritical Fluids (2008) *
O.R. Justo et al. "Anti Inflammatory Effects Of Ginger And Rosemary Extracts Obtained By Supercritical Fluid Technology", In: 11th European Meeting on Supercritical Fluids (2008)*
박창수. "미나리 발효액으로부터 간기능 활성화 음료의 개발" 과제 최종연구보고서. 과천: 농림수산식품부 (2008) *
박창수. "미나리 발효액으로부터 간기능 활성화 음료의 개발" 과제 최종연구보고서. 과천: 농림수산식품부 (2008)*

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240036213A (en) 2022-09-13 2024-03-20 위즈티앤티 주식회사 Baby bottom cleanser composition Composition comprising ginger and herbal extract for anti-bacteria
KR20240036214A (en) 2022-09-13 2024-03-20 위즈티앤티 주식회사 Cleaning composition for girl comprising ginger and complex extract having anti-fungi

Also Published As

Publication number Publication date
KR20130088665A (en) 2013-08-08
WO2013115456A1 (en) 2013-08-08

Similar Documents

Publication Publication Date Title
US11026441B2 (en) Avocado flesh and/or skin extract rich in polyphenols and cosmetic, dermatological and nutraceutical compositions comprising same
US20200085897A1 (en) Extract of Aerial Parts of Maca Rich in Polyphenols and Composition Comprising Same
EP2987536A1 (en) Oral preparation, injection preparation, external skin preparation and cosmetic method for preventing or improving wrinkles
KR101964809B1 (en) Inhibitor for NO activator, Anit-inflammation agent containing of the same, Revitalizing cosmetics containing the same and Manufacturing method thereof
KR102033089B1 (en) Compositions for decreasing sebum, skin desquamation and skin suppression
JP2009126863A (en) Composition highly containing ergothioneine extracted from mushroom
KR101017709B1 (en) Cosmetic composition comprising the herbal mixed extract comprising panax ginseng c.a meyer showing hair-growth stimulating activity and preventing activity from hair loss
KR102113193B1 (en) Composition for improving skin conditions comprising artemisiae annuae herba, centella asiatica and green tea extract or fraction thereof and method for improving skin conditions using the same
CN113694115A (en) Application of Fuzhuan tea extract in preparation of skin conditioning product
JP2006124350A (en) Nmf production promoter
KR101347910B1 (en) a Food Composition, a Cosmetic Composition, a Pharmaceutical Composition Comprising Supercritical Fluid Extract of Ginger and Extract of Dropwort Fermented
KR100776346B1 (en) A composition comprising an extract eclipta prostrata l., rehmannia glutinosa liboschtz var. purpurea makino, polygonum multiflorium thunb. and pinellia ternata breit. showing anti-dandruff and anti-inflammatory activity
KR102300581B1 (en) Compositions for improving skin conditions comprising plant extracts or fractions thereof
KR102063686B1 (en) Skin external composition containing extract of soybean root
KR102214985B1 (en) Compositions for improving skin conditions comprising plant extracts or fractions thereof
KR101820531B1 (en) Composition for preventing hair loss or promoting hair growth with Nipa fruticans wurmb
JP6753602B2 (en) Proton pump function accelerator
KR100888753B1 (en) Composition comprising an extract of Cornus kousa or the compounds isolated therefrom having anti-aging and anti-wrinkle activity
JP2008303147A (en) External preparation for skin
JP4247091B2 (en) Skin anti-aging agent
KR101501538B1 (en) Composition for External Application to the Skin Using an Extract of Seeds of Opuntia ficus-indica var. saboten
JP2005023021A (en) Elastase inhibitor
JP2003342179A (en) Agent for aging prevention
KR101985660B1 (en) Cosmetic composition for treating acne containing mixed herbal extracts fermented with Nuruk
KR100909729B1 (en) Cosmetic composition for preventing and improving acne containing Namsil extract

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20161219

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20171106

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20181210

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20191126

Year of fee payment: 7

R401 Registration of restoration